NCT01823510 - Ticagrelor Versus Clopidogrel in Type 2 Diabetic Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

May 10, 2016

Study Completion Date

May 10, 2016

Conditions

Type-2 Diabetes MellitusCoronary Artery Disease

Interventions

DRUG

Ticagrelor + Aspirin

Single loading doses of Ticagrelor (180 mg) and ASA (325 mg), followed by daily dosing for 5-7 days (ticagrelor 90 mg twice daily + ASA 81 mg once daily).

DRUG

Clopidogrel + Aspirin

Single loading doses of Clopidogrel (600 mg) and ASA (325 mg), followed by daily dosing for 5-7 days (clopidogrel 75 mg + ASA 81 mg once daily).

Trial Locations (1)

10029

Icahn School of Medicine at Mount Sinai, New York